vs
Healthpeak Properties（DOC）与PROCORE TECHNOLOGIES, INC.（PCOR）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是PROCORE TECHNOLOGIES, INC.的2.0倍（$702.9M vs $359.3M），Healthpeak Properties净利率更高（51.6% vs -2.5%，领先54.2%），PROCORE TECHNOLOGIES, INC.同比增速更快（15.7% vs -6.6%），过去两年PROCORE TECHNOLOGIES, INC.的营收复合增速更高（12.4% vs 0.5%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Procore Technologies是2002年成立的美国建筑管理软件即服务（SaaS）企业，总部位于加利福尼亚州卡平特里亚。公司打造的全球平台可连接建筑行业从业者，支持搭建简化工作流，统一展现建筑项目信息，覆盖任务追踪、项目流程管理、日程排期等核心功能。
DOC vs PCOR — 直观对比
营收规模更大
DOC
是对方的2.0倍
$359.3M
营收增速更快
PCOR
高出22.3%
-6.6%
净利率更高
DOC
高出54.2%
-2.5%
两年增速更快
PCOR
近两年复合增速
0.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $359.3M |
| 净利润 | $363.0M | $-9.1M |
| 毛利率 | — | 80.1% |
| 营业利润率 | 0.7% | 15.5% |
| 净利率 | 51.6% | -2.5% |
| 营收同比 | -6.6% | 15.7% |
| 净利润同比 | 28.3% | 72.4% |
| 每股收益（稀释后） | $0.28 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCPCOR
| Q1 26 | $702.9M | $359.3M | ||
| Q4 25 | $719.4M | $349.1M | ||
| Q3 25 | $705.9M | $338.9M | ||
| Q2 25 | $694.3M | $323.9M | ||
| Q1 25 | $702.9M | $310.6M | ||
| Q4 24 | $698.0M | $302.0M | ||
| Q3 24 | $700.4M | $295.9M | ||
| Q2 24 | $695.5M | $284.3M |
净利润DOCPCOR
| Q1 26 | $363.0M | $-9.1M | ||
| Q4 25 | $114.0M | $-37.6M | ||
| Q3 25 | $-117.1M | $-9.1M | ||
| Q2 25 | $31.7M | $-21.1M | ||
| Q1 25 | $42.8M | $-33.0M | ||
| Q4 24 | $4.5M | $-62.3M | ||
| Q3 24 | $85.9M | $-26.4M | ||
| Q2 24 | $146.0M | $-6.3M |
毛利率DOCPCOR
| Q1 26 | — | 80.1% | ||
| Q4 25 | — | 80.1% | ||
| Q3 25 | 58.6% | 79.7% | ||
| Q2 25 | 60.2% | 79.1% | ||
| Q1 25 | 61.1% | 79.1% | ||
| Q4 24 | 60.3% | 81.2% | ||
| Q3 24 | 60.0% | 81.4% | ||
| Q2 24 | 60.6% | 83.1% |
营业利润率DOCPCOR
| Q1 26 | 0.7% | 15.5% | ||
| Q4 25 | 17.4% | -12.3% | ||
| Q3 25 | 9.2% | -4.4% | ||
| Q2 25 | 5.7% | -9.3% | ||
| Q1 25 | 7.7% | -11.7% | ||
| Q4 24 | -2.2% | -21.9% | ||
| Q3 24 | 14.1% | -12.3% | ||
| Q2 24 | 22.3% | -5.2% |
净利率DOCPCOR
| Q1 26 | 51.6% | -2.5% | ||
| Q4 25 | 73.2% | -10.8% | ||
| Q3 25 | -16.6% | -2.7% | ||
| Q2 25 | 4.6% | -6.5% | ||
| Q1 25 | 6.1% | -10.6% | ||
| Q4 24 | 0.7% | -20.6% | ||
| Q3 24 | 12.3% | -8.9% | ||
| Q2 24 | 21.0% | -2.2% |
每股收益（稀释后）DOCPCOR
| Q1 26 | $0.28 | $-0.06 | ||
| Q4 25 | $0.16 | $-0.25 | ||
| Q3 25 | $-0.17 | $-0.06 | ||
| Q2 25 | $0.05 | $-0.14 | ||
| Q1 25 | $0.06 | $-0.22 | ||
| Q4 24 | $0.02 | $-0.42 | ||
| Q3 24 | $0.12 | $-0.18 | ||
| Q2 24 | $0.21 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $386.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.8B | $1.2B |
| 总资产 | $21.6B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCPCOR
| Q1 26 | $-1.2B | $386.0M | ||
| Q4 25 | $467.5M | $768.5M | ||
| Q3 25 | $91.0M | $684.0M | ||
| Q2 25 | $89.4M | $620.9M | ||
| Q1 25 | $70.6M | $566.7M | ||
| Q4 24 | $119.8M | $775.4M | ||
| Q3 24 | $180.4M | $756.9M | ||
| Q2 24 | $106.9M | $735.4M |
总债务DOCPCOR
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | — | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — |
股东权益DOCPCOR
| Q1 26 | $7.8B | $1.2B | ||
| Q4 25 | $7.5B | $1.3B | ||
| Q3 25 | $7.6B | $1.2B | ||
| Q2 25 | $7.9B | $1.2B | ||
| Q1 25 | $8.2B | $1.2B | ||
| Q4 24 | $8.4B | $1.3B | ||
| Q3 24 | $8.6B | $1.3B | ||
| Q2 24 | $8.8B | $1.3B |
总资产DOCPCOR
| Q1 26 | $21.6B | $2.1B | ||
| Q4 25 | $20.3B | $2.2B | ||
| Q3 25 | $19.6B | $2.1B | ||
| Q2 25 | $19.8B | $2.0B | ||
| Q1 25 | $19.8B | $1.9B | ||
| Q4 24 | $19.9B | $2.1B | ||
| Q3 24 | $20.0B | $2.0B | ||
| Q2 24 | $20.2B | $2.0B |
负债/权益比DOCPCOR
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $76.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCPCOR
| Q1 26 | — | $76.8M | ||
| Q4 25 | $1.3B | $114.9M | ||
| Q3 25 | $315.0M | $88.5M | ||
| Q2 25 | $363.5M | $30.8M | ||
| Q1 25 | $279.4M | $66.0M | ||
| Q4 24 | $1.1B | $29.1M | ||
| Q3 24 | $318.2M | $39.3M | ||
| Q2 24 | $316.2M | $58.7M |
自由现金流DOCPCOR
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $109.2M | ||
| Q3 25 | — | $83.1M | ||
| Q2 25 | — | $27.9M | ||
| Q1 25 | — | $62.0M | ||
| Q4 24 | $333.7M | $17.4M | ||
| Q3 24 | — | $35.7M | ||
| Q2 24 | — | $56.8M |
自由现金流率DOCPCOR
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | 31.3% | ||
| Q3 25 | — | 24.5% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | 47.8% | 5.8% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 20.0% |
资本支出强度DOCPCOR
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | 1.6% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 105.6% | 3.9% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.7% |
现金转化率DOCPCOR
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.48× | — | ||
| Q1 25 | 6.52× | — | ||
| Q4 24 | 235.43× | — | ||
| Q3 24 | 3.71× | — | ||
| Q2 24 | 2.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
PCOR
暂无分部数据
